Curcumin Modulates the Inflammatory Response and Inhibits Subsequent Fibrosis in a Mouse Model of Viral-induced Acute Respiratory Distress Syndrome

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Avasarala, Sreedevi ^a,b   Zhang, Fangfang ^a   Liu, Guangliang ^a   Wang, Ruixue ^a   London, Steven D ^a   London, Lucille ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CURCUMIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TENASCIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LUNG FIBROSIS; MAMMALIAN ORTHOREOVIRUS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; VIRUS PNEUMONIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOKINE CCL2; CURCUMIN; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GENE EXPRESSION; HUMANS; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MICE, INBRED CBA; ORTHOREOVIRUS, MAMMALIAN; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REOVIRIDAE INFECTIONS; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION; TENASCIN; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84874233851     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057285     Document Type: Article

References (87)

1. Ware LB, Matthay MA, (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
2. Matthay M, Zimmerman G, (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Resp Cell Mol Biol 33: 319-327.
3. Ley B, Collard HR, King TE Jr, (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183: 431-440.
4. Matute-Bello G, Frevert CW, Martin TR, (2008) Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 295: L379-399.
5. London L, Majeski EI, Altman-Hamamdzic S, Enockson C, Paintlia MK, et al. (2002) Respiratory reovirus 1/L induction of diffuse alveolar damage: pulmonary fibrosis is not modulated by corticosteroids in acute respiratory distress syndrome in mice. Clin Immunol 103: 284-295.
6. London L, Majeski EI, Paintlia MK, Harley RA, London SD, (2002) Respiratory reovirus 1/L induction of diffuse alveolar damage: a model of acute respiratory distress syndrome. Exp Mol Pathol 72: 24-36.
7. Majeski EI, Harley RA, Bellum SC, London SD, London L, (2003) Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol 28: 208-217.
8. Majeski EI, Paintlia MK, Lopez AD, Harley RA, London SD, et al. (2003) Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes. Am J Pathol 163: 1467-1479.
9. Lopez AD, Avasarala S, Grewal S, Murali AK, London L, (2009) Differential role of the Fas/Fas ligand apoptotic pathway in inflammation and lung fibrosis associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia and acute respiratory distress syndrome. J Immunol 183: 8244-8257.
10. Srimal RC, Dhawan BN, (1973) Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 25: 447-452.
11. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC, (2006) Multiple biological activities of curcumin: a short review. Life Sci 78: 2081-2087.
12. Sharma OP, (1976) Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25: 1811-1812.
13. Stengler M, Balch JF (2002) Natural Physician's Healing Therapies: Prentice Hall Publishers, USA. pgs 444-446.
14. Sharma RA, Gescher AJ, Steward WP, (2005) Curcumin: the story so far. Eur J Cancer 41: 1955-1968.
15. Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, et al. (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10: 6847-6854.
16. Aggarwal BB, Harikumar KB, (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41: 40-59.
17. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, et al. (2008) Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 76: 1590-1611.
18. Aggarwal BB, Kumar A, Aggarwal MS, et al. (2005) Curcumin derived from turmeric (Curcuma longa): a spice for all seasons;. Preuss PDDBHG, editor. New York: CRC Press pg 350-378.
19. Joe B, Vijaykumar M, Lokesh BR, (2004) Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44: 97-111.
20. Tourkina E, Gooz P, Oates JC, Ludwicka-Bradley A, Silver RM, et al. (2004) Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31: 28-35.
21. Tourkina E, Hoffman S, Fenton JW 2nd, Lipsitz S, Silver RW, et al. (2001) Depletion of protein kinase Cepsilon in normal and scleroderma lung fibroblasts has opposite effects on tenascin expression. Arthritis Rheum 44: 1370-1381.
22. Punithavathi D, Venkatesan N, Babu M, (2000) Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats. Br J Pharmacol 131: 169-172.
23. Punithavathi D, Venkatesan N, Babu M, (2003) Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br J Pharmacol 139: 1342-1350.
24. Venkatesan N, Chandrakasan G, (1995) Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 142: 79-87.
25. Venkatesan N, Punithavathi V, Chandrakasan G, (1997) Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61: PL51-58.
26. Venkatesan N, (2000) Pulmonary protective effects of curcumin against paraquat toxicity. Life Sci 66: PL21-28.
27. Literat A, Su F, Norwicki M, Durand M, Ramanathan R, et al. (2001) Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci 70: 253-267.
28. Biswas SK, McClure D, Jimenez LA, Megson IL, Rahman I, (2005) Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7: 32-41.
29. Zhu RF, Zhou M, He JL, Ding FY, Yu SQ, et al. (2008) [Protective effect of curcumin on oleic-induced acute lung injury in rats]. Zhongguo Zhong Yao Za Zhi 33: 2141-2145.
30. Nahra R, Dellinger RP, (2008) Targeting the lipopolysaccharides: still a matter of debate? Curr Opin Anaesthesiol 21: 98-104.
31. Tham CL, Lam KW, Rajajendram R, Cheah YK, Sulaiman MR, et al. (2011) The effects of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxyl-3-methoxybenzylidine)cyclohexanone on proinflammatory signaling pathways and CLP-induced lethal sepsis in mice. Eur J Pharmacol 652: 136-144.
32. Thiemermann C, (2006) The spice of life: curcumin reduces the mortality associated with experimental sepsis. Crit Care Med 34: 2009-2011.
33. Vachharajani V, Wang SW, Mishra N, El Gazzar M, Yoza B, et al. (2010) Curcumin modulates leukocyte and platelet adhesion in murine sepsis. Microcirculation 17: 407-416.
34. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, et al. (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18: 1606-1614.
35. Guzel A, Kanter M, Aksu B, Basaran UN, Yalcin O, et al. (2009) Preventive effects of curcumin on different aspiration material-induced lung injury in rats. Pediatr Surg Int 25: 83-92.
36. Bellum SC, Dove D, Harley RA, Greene WB, Judson MA, et al. (1997) Respiratory reovirus 1/L induction of intraluminal fibrosis. A model for the study of bronchiolitis obliterans organizing pneumonia. Am J Pathol 150: 2243-2254.
37. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, et al. (2000) Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 162: 2295-2301.
38. Laitinen A, Altraja A, Kampe M, Linden M, Virtanen I, et al. (1997) Tenascin is increased in airway basement membrane of asthmatics and decreased by an inhaled steroid. Am J Respir Crit Care Med 156: 951-958.
39. Kaarteenaho-Wiik R, Lakari E, Soini Y, Pollanen R, Kinnula VL, et al. (2000) Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem 48: 1257-1268.
40. Paakko P, Kaarteenaho-Wiik R, Pollanen R, Soini Y, (2000) Tenascin mRNA expression at the foci of recent injury in usual interstitial pneumonia. Am J Respir Crit Care Med 161: 967-972.
41. Del Sorbo L, Slutsky AS, (2011) Acute respiratory distress syndrome and multiple organ failure. Curr Opin Crit Care 17: 1-6.
42. Creagh-Brown BC, Griffiths MJ, Evans TW, (2009) Bench-to-bedside review: Inhaled nitric oxide therapy in adults. Crit Care 13: 221.
43. Lee PJ, (2005) An old spice with new twists: curcumin, p38 mitogen-activated protein kinase, and apoptosis. Crit Care Med 33: 2703-2705.
44. Baldwin AS Jr, (2001) Series introduction: the transcription factor NF-kappaB and human disease. J Clin Invest 107: 3-6.
45. Tak PP, Firestein GS, (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107: 7-11.
46. Morris GF, (2010) An alternative to lung inflammation and fibrosis. Am J Pathol 176: 2595-2598.
47. Han W, Joo M, Everhart MB, Christman JW, Yull FE, et al. (2009) Myeloid cells control termination of lung inflammation through the NF-kappaB pathway. Am J Physiol Lung Cell Mol Physiol 296: L320-327.
48. Tully JE, Nolan JD, Guala AS, Hoffman SM, Roberson EC, et al. (2012) Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells. Am J of Resp Cell Mol Biol 47: 497-508.
49. Yang KY, Arcaroli JJ, Abraham E, (2003) Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med 167: 1567-1574.
50. Moine P, McIntyre R, Schwartz MD, Kaneko D, Shenkar R, et al. (2000) NF-kappaB regulatory mechanisms in alveolar macrophages from patients with acute respiratory distress syndrome. Shock 13: 85-91.
51. Arnalich F, Garcia-Palomero E, Lopez J, Jimenez M, Madero R, et al. (2000) Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun 68: 1942-1945.
52. Bohrer H, Qiu F, Zimmermann T, Zhang Y, Jllmer T, et al. (1997) Role of NFkappaB in the mortality of sepsis. J Clin Invest 100: 972-985.
53. Singh S, Aggarwal BB, (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270: 24995-25000.
54. Kim GY, Kim KH, Lee SH, Yoon MS, Lee HJ, et al. (2005) Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174: 8116-8124.
55. Liu K, Chen HL, Huang H, Jing H, Dong GH, et al. (2012) Curcumin Attenuates Cardiopulmonary Bypass-Induced Lung Oxidative Damage in Rats. J Cardiovasc Pharmacol Ther 17: 395-402.
56. Liu K, Shen L, Wang J, Dong G, Wu H, et al. (2012) The preventative role of curcumin on the lung inflammatory response induced by cardiopulmonary bypass in rats. J Surg Res 174: 73-82.
57. Oh SW, Cha JY, Jung JE, Chang BC, Kwon HJ, et al. (2011) Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. J Ethnopharmacol 136: 414-421.
58. Prud'homme GJ, (2007) Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations. Lab Invest 87: 1077-1091.
59. Gauldie J, Bonniaud P, Sime P, Ask K, Kolb M, (2007) TGF-beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans 35: 661-664.
60. Scotton CJ, Chambers RC, (2007) Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132: 1311-1321.
61. Dhainaut JF, Charpentier J, Chiche JD, (2003) Transforming growth factor-beta: a mediator of cell regulation in acute respiratory distress syndrome. Crit Care Med 31: S258-264.
62. Budinger GR, Chandel NS, Donnelly HK, Eisenbart J, Oberoi M, et al. (2005) Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 31: 121-128.
63. Fahy RJ, Lichtenberger F, McKeegan CB, Nuovo GJ, Marsh CB, et al. (2003) The acute respiratory distress syndrome: a role for transforming growth factor-beta 1. Am J Respir Cell Mol Biol 28: 499-503.
64. Thresiamma KC, George J, Kuttan R, (1996) Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity. Indian J Exp Biol 34: 845-847.
65. Cutroneo KR, White SL, Phan SH, Ehrlich HP, (2007) Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta1 induced collagen gene expression. J Cell Physiol 211: 585-589.
66. Xu M, Deng B, Chow YL, Zhao ZZ, Hu B, (2007) Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. J Ethnopharmacol 112: 292-299.
67. Chen B, Zhang DP, Gao W, (2008) [Effect of curcumin on the expression of collagen type I protein and transforming growth factor-beta1 mRNA in pulmonary fibrosis rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 26: 257-261.
68. Zhang DP, Qiu H, Zhuang Y, Meng FQ, (2007) [The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats]. Zhonghua Jie He He Hu Xi Za Zhi 30: 197-201.
69. Smith MR, Gangireddy SR, Narala VR, Hogaboam CM, Standiford TJ, et al. (2010) Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol 298: L616-625.
70. Jiang ZY, Zou L, Shi SS, Lu YR, Dong J, et al. (2009) [Effects of curcumin on TNF-alpha and TGF-beta1 in serum and lung tissue of SiO2-induced fibrosis in mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 25: 399-401.
71. Song K, Peng S, Sun Z, Li H, Yang R, (2011) Curcumin suppresses TGF-beta signaling by inhibition of TGIF degradation in scleroderma fibroblasts. Biochem Biophys Res Commun 411: 821-825.
72. Jimenez SA, Gaidarova S, Saitta B, Sandorfi N, Herrich DJ, et al. (2001) Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 108: 1395-1403.
73. Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC, (2010) Suppression of TGF-beta1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res 302: 717-724.
74. Gaedeke J, Noble NA, Border WA, (2004) Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66: 112-120.
75. Meier M, Menne J, Park JK, Holtz M, Gueler F, et al. (2007) Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. J Am Soc Nephrol 18: 1190-1198.
76. Zheng S, Chen A, (2004) Activation of PPARgamma is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 384: 149-157.
77. Zheng S, Chen A, (2006) Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290: G883-893.
78. Zheng S, Chen A, (2007) Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 292: G113-123.
79. Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, et al. (1999) Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 163: 2217-2225.
80. Martin TR, Hagimoto N, Nakamura M, Matute-Bello G, (2005) Apoptosis and epithelial injury in the lungs. Proc Am Thorac Soc 2: 214-220.
81. Albertine KH, Soulier MF, Wang Z, Ishizaka A, Hashimoto S, et al. (2002) Fas and fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome. Am J Pathol 161: 1783-1796.
82. Nick JA, Avdi NJ, Young SK, Lehman LA, McDonald PP, et al. (1999) Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 103: 851-858.
83. Hu M, Du Q, Vancurova I, Lin X, Miller EJ, et al. (2005) Proapoptotic effect of curcumin on human neutrophils: activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 33: 2571-2578.
84. Wang Y, Rishi AK, Wu W, Polin L, Sharma S, et al. (2011) Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis. Mol Cell Biochem 357: 83-94.
85. Lee JY, Lee YM, Chang GC, Yu SL, Hsieh WY, et al. (2011) Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy. PLoS One 6: e23756.
86. Suresh MV, Wagner MC, Rosania GR, Stringer KA, Min KA, et al. (2012) Pulmonary administration of a water-soluble curcumin complex reduces severity of acute lung injury. Am J Respir Cell Mol Biol 47: 280-287.
87. Bansal S, Chhibber S, (2010) Curcumin alone and in combination with augmentin protects against pulmonary inflammation and acute lung injury generated during Klebsiella pneumoniae B5055-induced lung infection in BALB/c mice. J Med Microbiol 59: 429-437.